Dr Reddy’s inks pact with Gilead to manufacture, market Remdesivir in India

Dr. Reddy’s Laboratories on Saturday said it has signed a non-exclusive licensing agreement with Gilead Sciences to register, manufacture and sell the U.S. biopharmaceutical firm’s antiviral drug remdesivir that has emerged as a potential treatment…